Haleon Completes Acquisition of Remaining Equity Interest in Tianjin TSKF Pharmaceutical

MT Newswires Live

2025/06/27

Haleon (HLN) said in a regulatory filing Friday it has completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical, the company's joint venture in China, for 1.62 billion Chinese renminbi ($226.4 million).

According to the company, the deal will allow it to drive category growth in one of the fastest-growing OTC markets globally.

As a result of the transaction, Tianjin TSKF Pharmaceutical is now a wholly-owned subsidiary of Haleon, the company said.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2546435887"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546435887\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546435887?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-27 19:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546435887","market":"sh","top_or_hot":-1,"title":"Haleon Completes Acquisition of Remaining Equity Interest in Tianjin TSKF Pharmaceutical","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HLN\">Haleon</a> (HLN) said in a regulatory filing Friday it has completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical, the company's joint venture in China, for 1.62 billion Chinese renminbi ($226.4 million).</p><p>According to the company, the deal will allow it to drive category growth in one of the fastest-growing OTC markets globally.</p><p>As a result of the transaction, Tianjin TSKF Pharmaceutical is now a wholly-owned subsidiary of Haleon, the company said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haleon Completes Acquisition of Remaining Equity Interest in Tianjin TSKF Pharmaceutical</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaleon Completes Acquisition of Remaining Equity Interest in Tianjin TSKF Pharmaceutical\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-06-27 19:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HLN\">Haleon</a> (HLN) said in a regulatory filing Friday it has completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical, the company's joint venture in China, for 1.62 billion Chinese renminbi ($226.4 million).</p><p>According to the company, the deal will allow it to drive category growth in one of the fastest-growing OTC markets globally.</p><p>As a result of the transaction, Tianjin TSKF Pharmaceutical is now a wholly-owned subsidiary of Haleon, the company said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2546435887","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546435887","pubTimestamp":1751025359,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Haleon  said in a regulatory filing Friday it has completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical, the company's joint venture in China, for 1.62 billion Chinese renminbi .According to the company, the deal will allow it to drive category growth in one of the fastest-growing OTC markets globally.As a result of the transaction, Tianjin TSKF Pharmaceutical is now a wholly-owned subsidiary of Haleon, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BK4215":"住宅房地产投资信托","EQR":"资产住宅公司","BK4588":"碎股","BK4183":"个人用品","BK4585":"ETF&股票定投概念","HLN":"Haleon"},"translate_title":"Haleon完成收购天津TSKF Pharmaceutical馀下股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLN":1,"EQR":1},"content_text":"Haleon (HLN) said in a regulatory filing Friday it has completed the acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical, the company's joint venture in China, for 1.62 billion Chinese renminbi ($226.4 million).According to the company, the deal will allow it to drive category growth in one of the fastest-growing OTC markets globally.As a result of the transaction, Tianjin TSKF Pharmaceutical is now a wholly-owned subsidiary of Haleon, the company said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}